Â¥
6.65
Jan 15
New Key Statistics Module, Z-Score and F-Score
SHSE:603168 Key Ratios
Market Cap ¥ M | 2,499.90 |
Enterprise Value ¥ M | 2,565.26 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | 655.27 |
Price/Book | 1.48 |
Price/Sales | 4.71 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 505.00 |
EPS (TTM) ¥ | -0.22 |
Beneish M-Score | -2.93 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -186.10 |
EV-to-EBIT | -36.27 |
EV-to-EBITDA | -36.27 |
PEG | -- |
Shares Outstanding M | 375.93 |
Net Margin (%) | -16.77 |
Operating Margin % | -13.97 |
Pre-tax Margin (%) | -15.19 |
Quick Ratio | 1.04 |
Current Ratio | 1.31 |
ROA % (ttm) | -3.97 |
ROE % (ttm) | -4.93 |
ROIC % (ttm) | -4.19 |
Dividend Yield % | 0.31 |
Altman Z-Score | 3.76 |
SHSE:603168 Number of Guru Trades
SHSE:603168 Volume of Guru Trades
Gurus Latest Trades with SHSE:603168
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603168 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Shapuaisi Pharmaceutical Co Ltd Insider Transactions
No Available Data